Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer

The purpose was to investigate the interrater agreement of FDG-PET/CT and bone scintigraphy for diagnosing bone recurrence in breast cancer patients. A total of 100 women with suspected recurrence of breast cancer underwent planar whole-body bone scintigraphy with [99mTc]DPD and FDG-PET/CT. Scans we...

Descripción completa

Detalles Bibliográficos
Autores principales: Holm, Jorun, Ahangarani Farahani, Ziba, Gerke, Oke, Baun, Christina, Falch, Kirsten, Malene Grubbe, Hildebrandt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760596/
https://www.ncbi.nlm.nih.gov/pubmed/33260766
http://dx.doi.org/10.3390/diagnostics10121021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760596/
https://www.ncbi.nlm.nih.gov/pubmed/33260766
http://dx.doi.org/10.3390/diagnostics10121021

Ejemplares similares